← Back to Search
Advancements In Anti-inflammatory Therapy For Dry Eye Syndrome.
E. McCabe, S. Narayanan
Published 2009 · Medicine
Download PDFAnalyze on Scholarcy
PURPOSE The goal of this literature review is to discuss recent discoveries in the pathophysiology of dry eye and the subsequent evolution of diagnostic and management techniques. The mechanisms of various anti-inflammatory treatments are reviewed, and the efficacy of common pharmacologic agents is assessed. Anti-inflammatory therapy is evaluated in terms of its primary indications, target population, and utility within a clinical setting. METHODS The Medline PubMed database and the World Wide Web were searched for current information regarding dry eye prevalence, pathogenesis, diagnosis, and management. After an analysis of the literature, major concepts were integrated to generate an updated portrayal of the status of dry eye syndrome. RESULTS Inflammation appears to play a key role in perpetuating and sustaining dry eye. Discoveries of inflammatory markers found within the corneal and conjunctival epithelium of dry eye patients have triggered recent advancements in therapy. Pharmacologic anti-inflammatory therapy for dry eye includes 2 major categories: corticosteroids and immunomodulatory agents. Fatty acid and androgen supplementation and oral antibiotics have also shown promise in dry eye therapy because of their anti-inflammatory effects. CONCLUSIONS Anti-inflammatory pharmacologic agents have shown great success in patients with moderate to severe dry eye when compared with alternative treatment modalities. A deeper understanding of the link between inflammation and dry eye validates the utilization of anti-inflammatory therapy in everyday optometric practice.
This paper references
The Economic Burden of Dry Eye: A Conceptual Framework and Preliminary Assessment
P. Reddy (2004)
Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease
B. Noble (2004)
A randomised, crossover, multicentre study to compare the performance of 0.1% (w/v) sodium hyaluronate with 1.4% (w/v) polyvinyl alcohol in the alleviation of symptoms associated with dry eye syndrome
C. C. McDonald (2002)
Interleukin-6 Levels in the Conjunctival Epithelium of Patients with Dry Eye Disease Treated with Cyclosporine Ophthalmic Emulsion
K. Turner (2000)
Topical ciclosporin in the treatment of ocular surface disorders
S. Tatlıpınar (2005)
Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye.
C. S. de Paiva (2006)
Conjunctival T-cell subpopulations in Sjögren's and non-Sjögren's patients with dry eye.
M. Stern (2002)
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance.
S. Pflugfelder (2004)
Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome.
P. Marsh (1999)
The Lack of Association Between Signs and Symptoms in Patients With Dry Eye Disease
K. Nichols (2004)
Mechanisms of action of cyclosporine.
S. Matsuda (2000)
Dry eye diagnosis and management in 2004
H. Perry (2004)
Effects of Sequential Artificial Tear and Cyclosporine Emulsion Therapy on Conjunctival Goblet Cell Density and Transforming Growth Factor-β2 Production
S. Pflugfelder (2008)
Why the eye becomes dry: a cornea and lacrimal gland feedback model.
W. Mathers (2000)
Performance profile of sodium hyaluronate in patients with lipid tear deficiency: randomised, double-blind, controlled, exploratory study
P. Prabhasawat (2007)
Cyclosporine A delivery to the eye: a pharmaceutical challenge.
F. Lallemand (2003)
Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys.
W. Trattler (2006)
Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
L. D. Barber (2005)
JNK and ERK MAP kinases mediate induction of IL-1β, TNF-α and IL-8 following hyperosmolar stress in human limbal epithelial cells
D. Li (2006)
Spontaneous canine keratoconjunctivitis sicca. A useful model for human keratoconjunctivitis sicca: treatment with cyclosporine eye drops.
R. Kaswan (1989)
The role of apoptosis in the pathogenesis of canine keratoconjunctivitis sicca: the effect of topical Cyclosporin A therapy.
J. Gao (1998)
Tear fluid gelatinase B activity correlates with IL-1alpha concentration and fluorescein clearance in ocular rosacea.
A. A. Afonso (1999)
Stimulation of matrix metalloproteinases by hyperosmolarity via a JNK pathway in human corneal epithelial cells.
D. Li (2004)
Sodium hyaluronate eyedrops in the treatment of dry eyes.
S. Shimmura (1995)
Self-reported dry eyes and diabetic history.
M. Hom (2006)
Does androgen insufficiency cause lacrimal gland inflammation and aqueous tear deficiency?
D. Sullivan (1999)
Antiinflammatory therapy for dry eye.
S. Pflugfelder (2004)
Changes in the tear film and ocular surface from dry eye syndrome
M. E. Johnson (2004)
Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment.
S. Wilson (2007)
Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
A. Solomon (2001)
GDNF family signalling in exocrine tissues: distinct roles for GDNF and neurturin in parasympathetic neuron development.
J. Rossi (2002)
Tear flow in cyclosporine recipients.
S. L. Palmer (1995)
Doxycycline inhibits TGF-beta1-induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells.
H. Kim (2005)
The ocular surface and tear film and their dysfunction in dry eye disease.
M. Rolando (2001)
Investigation of Corneal Effect of Different Types of Artificial Tears in a Simulated Dry Eye Condition Using a Novel Porcine Dry Eye Model (pDEM)
Emily Pik Yin Choy (2006)
The pathology of dry eye: the interaction between the ocular surface and lacrimal glands.
M. Stern (1998)
Dry eye in diabetic patients.
I. Kaiserman (2005)
Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca.
X. Song (2003)
Systemic omega-6 essential fatty acid treatment and pge1 tear content in Sjögren's syndrome patients.
P. Aragona (2005)
The pathology of dry eye.
C. Baudouin (2001)
The effect of punctal occlusion on tear production, tear clearance, and ocular surface sensation in normal subjects.
M. T. Yen (2001)
Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.
Bradley D Strong (2005)
The Diagnosis and Characteristics of Moderate Dry Eye in Non-Contact Lens Wearers
S. Narayanan (2005)
Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007).
S. Pflugfelder (2007)
Frequent association of delayed tear clearance in ocular irritation
P. Prabhasawat (1998)
The comparison of efficacies of topical corticosteroids and nonsteroidal anti-inflammatory drops on dry eye patients: a clinical and immunocytochemical study.
A. Avunduk (2003)
Effect of sodium hyaluronate (0.1%) on break-up time (NIBUT) in patients with dry eyes.
L. S. Mengher (1986)
Use of Macrolides and Tetracyclines for Chronic Inflammatory Diseases
Stacy A. Voils (2005)
Flow cytometric analysis of inflammatory markers in KCS: 6-month treatment with topical cyclosporin A.
F. Brignole (2001)
The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample.
P. Mertzanis (2005)
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group.
K. Sall (2000)
The impact of topical cyclosporine A emulsion 0.05% on the outcomes of patients with keratoconjunctivitis sicca
K. Stonecipher (2005)
Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine.
K. S. Kunert (2002)
Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.
F. Brignole (2000)
Recurrence after topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren's syndrome.
S. Hong (2007)
Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface.
Lihui Luo (2004)
Incidence of dry eye in an older population.
S. Moss (2004)
Biopsy of the Conjunctiva in Dry Eye Patients Establishes a Correlation between Squamous Metaplasia and Dry Eye Clinical Severity
J. Murube (2003)
Identification of androgen receptor protein and 5α-reductase mRNA in human ocular tissues
E. Rocha (2000)
Topical omega-3 and omega-6 fatty acids for treatment of dry eye.
S. Rashid (2008)
Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome.
M. Balaram (2001)
Autologous Serum Eye Drops for the Treatment of Dry Eye Diseases
T. Kojima (2008)
A clinical study of the efficacy of topical corticosteroids on dry eye
C. Yang (2006)
A Call to Arms
J. Gray (2005)
Efficacy and safety of 0.18% sodium hyaluronate in patients with moderate dry eye syndrome and superficial keratitis
F. Brignole (2004)
Systemic Linoleic and &ggr;-Linolenic Acid Therapy in Dry Eye Syndrome With an Inflammatory Component
S. Barabino (2003)
Relation between dietary n-3 and n-6 fatty acids and clinically diagnosed dry eye syndrome in women.
Biljana Miljanović (2005)
Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes.
M. Lemp (1995)
Real-world utilization patterns of cyclosporine ophthalmic emulsion 0.05% within managed care.
T. Chiang (2007)
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease1
K. Sall (2000)
Efficacy and safety of cyclosporin a ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: A dose-ranging, randomized trial☆
D. Stevenson (2000)
Prevalence of dry eye syndrome among US women.
D. Schaumberg (2003)
Carbomer and Sodium Hyaluronate Eyedrops for Moderate Dry Eye Treatment
M. E. Johnson (2008)
Dry eye and delayed tear clearance: "a call to arms.".
S. Pflugfelder (2002)
Sodium hyaluronate eye drops of different osmolarity for the treatment of dry eye in Sjögren's syndrome patients
P. Aragona (2002)
The conjunctival epithelium in dry eye subtypes: Effect of preserved and non-preserved topical treatments
J. Albietz (2001)
Evaluation of the clinical course of dry eye syndrome.
J. Horwath-Winter (2003)
Effect of androgen deficiency on the human meibomian gland and ocular surface.
K. Krenzer (2000)
Analysis of topical cyclosporine treatment of patients with dry eye syndrome: effect on conjunctival lymphocytes.
K. S. Kunert (2000)
Prevalence and associations of dry eye syndrome in an older population: the Blue Mountains Eye Study
Ee-Munn Chia (2003)
Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
A. Jain (2002)
Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
S. Narayanan (2006)
T Lymphocyte Activation Signals for Interleukin-2 Production Involve Activation of MKK6-p38 and MKK7-SAPK/JNK Signaling Pathways Sensitive to Cyclosporin A*
S. Matsuda (1998)
Dysfunctional Tear Syndrome: A Delphi Approach to Treatment Recommendations
A. Behrens (2006)
This paper is referenced by
Use of mini scleral contact lenses in moderate to severe dry eye.
F. Alipour (2012)
The management of dry eye
Michael A. Lemp (2016)
Comparison of prednisolone acetate and loteprednol etabonate for the treatment of benzalkonium chloride-induced dry eye syndrome in rats.
E. Beyazyıldız (2014)
Effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study
Andrea Oleñik (2014)
Dry Eye Profiles in Patients with a Positive Elevated Surface Matrix Metalloproteinase 9 Point-of-Care Test Versus Negative Patients.
N. Lanza (2016)
Nanotechnology and Regenerative Medicine A Novel Cyclosporin A Aqueous Formulation for Dry Eye Treatment : In Vitro and In Vivo Evaluation
C. D. Tommaso (2012)
The Role of Polymorphic Markers rs1478604, rs2292305, and rs2228262 in THBS1 Gene in the Development of Autoimmune Dry Eye Syndrome.
T. Safonova (2020)
Comparison of Prednisolone Acetate and Loteprednol Etabonate for the Treatment of Benzalkonium Chloride-Induced Dry Eye Syndrome in Rats
effectiveness and tolerability of dietary supplementation with a combination of omega-3 polyunsaturated fatty acids and antioxidants in the treatment of dry eye symptoms: results of a prospective study
Fundación Jiménez Díaz (2014)
Efficacy of Topical Mesenchymal Stem Cell Therapy in the Treatment of Experimental Dry Eye Syndrome Model
E. Beyazyıldız (2014)
A multicentre, double‐masked, randomized, controlled trial assessing the effect of oral supplementation of omega‐3 and omega‐6 fatty acids on a conjunctival inflammatory marker in dry eye patients
F. Brignole-Baudouin (2011)
Animal Models of Dry Eye Syndrome for Stem Cell Based Therapies
E. Beyazyıldız (2014)
Effect of Omega-3 Fatty Acids Dietary Supplementation on Ocular Surface and Tear Film in Diabetic Patients with Dry Eye
C. D. Georgakopoulos (2017)
Cyclosporine A Loaded PLGA Nanoparticles for Dry Eye Disease: In Vitro Characterization Studies
Vijay D. Wagh (2014)
Anti-inflammatory effects of hinokitiol on human corneal epithelial cells: an in vitro study
J. Ye (2015)
The management of dry eye
Drug and Therapeutics Bulletin (2016)
DRUG DELIVERY AND PHARMACOTHERAPY FOR DRY EYE DISEASE
Vijay D. Wagh (2012)
Determination of the Physiological Aqueous Tear Production Rate by Using Phenol Red Thread Test ( PRTT ) in Kangal Breed Dogs
Kadri Kulualp (2019)
Topical administration of interleukin-1 receptor antagonist as a therapy for aqueous-deficient dry eye in autoimmune disease
Trinka Vijmasi (2013)
Kangal Irkı Köpeklerde Fenol Kırmızısı Pamuk İpliği Testi (FKPT) Kullanılarak Fizyolojik Aköz Gözyaşı Üretim Miktarının Belirlenmesi
Kadri Kulualp (2019)
Colloidal systems for the delivery of cyclosporin A to the anterior segment of the eye.
C. Di Tommaso (2011)
Schirmer Tear Test 2 and Tear Break-Up Time values in a South African young black adult population
Naimah E. Khan (2012)
Interfacial phenomena and the ocular surface.
B. Yáñez-Soto (2014)
The Matrix Metalloproteinase 9 Point-of-Care Test in Dry Eye.
N. Lanza (2016)
Mapracorat, a novel selective glucocorticoid receptor agonist, inhibits hyperosmolar-induced cytokine release and MAPK pathways in human corneal epithelial cells
M. Cavet (2010)
Anti-Inflammatory and Anti-Apoptotic Effects of Acer Palmatum Thumb. Extract, KIOM-2015EW, in a Hyperosmolar-Stress-Induced In Vitro Dry Eye Model
Yeoun-Hee Kim (2018)
Compatibilidad y eficacia de las soluciones de limpieza y mantenimiento con las lentes de contacto terapéuticas y profilácticas con absorbancia selectiva de longitudes de onda corta
Cristina Álvarez Peregrina (2014)
Clinical Ophthalmology Dovepress
T. Mizoguchi ()